{"title":"T2D患者心肾代谢(CRM)状况的优化管理。","authors":"Jay H Shubrook, Joshua J Neumiller","doi":"10.12788/jfp.0622","DOIUrl":null,"url":null,"abstract":"<p><strong>Learning objectives: </strong>Describe cardio-renal-metabolic (CRM) conditions and their impact on health and patient-centered outcomes. Recognize current gaps in screening, risk factor management, and utilization of guideline-directed therapies in patients with CRM conditions. Select appropriate guideline-directed therapies for patients with type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease based on current guidelines and clinical evidence. Recognize the importance of multidisciplinary care when managing patients with CRM conditions.</p>","PeriodicalId":54836,"journal":{"name":"Journal of Family Practice","volume":"72 6 Suppl","pages":"S43-S48"},"PeriodicalIF":1.3000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimized Management of Cardio-Renal-Metabolic (CRM) Conditions in Patients With T2D.\",\"authors\":\"Jay H Shubrook, Joshua J Neumiller\",\"doi\":\"10.12788/jfp.0622\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Learning objectives: </strong>Describe cardio-renal-metabolic (CRM) conditions and their impact on health and patient-centered outcomes. Recognize current gaps in screening, risk factor management, and utilization of guideline-directed therapies in patients with CRM conditions. Select appropriate guideline-directed therapies for patients with type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease based on current guidelines and clinical evidence. Recognize the importance of multidisciplinary care when managing patients with CRM conditions.</p>\",\"PeriodicalId\":54836,\"journal\":{\"name\":\"Journal of Family Practice\",\"volume\":\"72 6 Suppl\",\"pages\":\"S43-S48\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Family Practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.12788/jfp.0622\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Family Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12788/jfp.0622","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Optimized Management of Cardio-Renal-Metabolic (CRM) Conditions in Patients With T2D.
Learning objectives: Describe cardio-renal-metabolic (CRM) conditions and their impact on health and patient-centered outcomes. Recognize current gaps in screening, risk factor management, and utilization of guideline-directed therapies in patients with CRM conditions. Select appropriate guideline-directed therapies for patients with type 2 diabetes, atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease based on current guidelines and clinical evidence. Recognize the importance of multidisciplinary care when managing patients with CRM conditions.
期刊介绍：
JFP is a peer-reviewed medical journal specifically intended to meet the needs of the specialty of family medicine. JFP is delivered to more than 95,000 family physicians as well as general practitioners and osteopaths in primary care.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
